Cargando…
Iodine repletion, thyrotoxicosis and atrial fibrillation in Isfahan, Iran
BACKGROUND: Iodized salt was reintroduced in Iran in 1989. Just before distribution of iodized salt thyrotoxicosis was observed in 3.7% of the patients with atrial fibrillation (AF) in university teaching hospitals in Isfahan, a centrally located city in Iran. As repletion of iodine may increase the...
Autores principales: | Aminorroaya, Ashraf, Rohani, Sina, Sattari, Goshtasb, Haghighi, Sasan, Amini, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147823/ https://www.ncbi.nlm.nih.gov/pubmed/15310007 http://dx.doi.org/10.5144/0256-4947.2004.13 |
Ejemplares similares
-
Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors
por: Janghorbani, Mohsen, et al.
Publicado: (2017) -
The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran
por: Mirzaei, Mohammad Reza, et al.
Publicado: (2012) -
Prevalence of Goitre in Isfahan, Iran, Fifteen Years After Initiation of Universal Salt Iodization
por: Ashraf, Aminorroaya, et al.
Publicado: (2010) -
Prevalence of Vitamin D Deficiency among Adult Population of Isfahan City, Iran
por: Hovsepian, Silva, et al.
Publicado: (2011) -
Thyroid function test reference ranges in the first trimester of gestation and pregnancy outcomes: Protocol and preliminary results for cohort population-based study Isfahan, Iran
por: Kianpour, Maryam, et al.
Publicado: (2018)